Skip to main content

Table 3 Change in clinical characteristics in individuals with progressive glycemic impairment after 2.5 years (n = 23)

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD or n (%) Baseline Follow up (2.5 Years) p-value
Systolic Blood Pressure (mm Hg) 119 ± 20 123 ± 13 0.235
Diastolic Blood Pressure (mm Hg) 71 ± 13 76 ± 13 0.081
Total Cholesterol (mg/dL) 188 ± 39 184 ± 30 0.364
LDL-c (mg/dL) 113 ± 33 106 ± 26 0.091
HDL-c (md/dL) 51 ± 16 51 ± 20 0.895
Triglycerides (mg/dL) 120 ± 65 137 ± 69 0.211
Fasting Blood Glucose (mg/dL) 91 ± 8 101 ± 18 0.008
Insulin (μIU/mL) 11.5 ± 6.2 17.8 ± 6.6 <0.001
HOMA-IR (μIU/mL*mmol/L) 2.6 ± 1.5 4.5 ± 2.1 <0.001
Body Mass Index (kg/m2) 25.7 ± 4.7 26.3 ± 4.9 0.065
Waist Circumference (cm) 93 ± 12 94 ± 13 0.796
  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation